10th January 2020
USADA announced today that Cristofer Martinez, of Miami, Fla., an athlete in the sport of weightlifting, has accepted a two-year suspension for an anti-doping rule violation.
Martinez, 28, tested positive for 5-methylhexan-2-amine as the result of an in-competition drug test conducted at the American Open Series 3 on September 14, 2019. 5-methylhexan-2-amine (also known as 1,4-dimethylpentylamine (DMPA) or 2-amino-5-methylhexane) is a Specified Substance in the category of Stimulants and is prohibited in competition under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policies, and the International Weightlifting Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
1,4-Dimethylpentylamine (DMPA) is very similar to 1,3-dimethylamylamine (DMAA) and 1,3-dimethylbutylamine (DMBA). All have been discovered in pre-workout supplements and the U.S. Food and Drug Administration (FDA) has put out specific warnings on
Martinez’s two-year period of ineligibility began on September 14, 2019, the date his positive sample was collected. In addition, Martinez has
been disqualified from competitive results obtained on and subsequent to September 14, 2019, including forfeiture of any medals, points and prizes.